Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: Fluorodeoxyglucose uptake corresponds with tumor perfusion

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 849-855

  Janssen, Marco H M ^a   Aerts, Hugo J W L ^a   Buijsen, Jeroen ^a   Lambin, Philippe ^a   Lammering, Guido ^a   Öllers, Michel C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

FDG uptake; FDG PET CT; Hypofractionated radiotherapy; Perfusion CT; Rectal cancer; Tumor perfusion

Indexed keywords

FDG UPTAKE; FDG-PET-CT; PERFUSION-CT; RECTAL CANCER; TUMOR PERFUSION;

COMPUTERIZED TOMOGRAPHY; DISEASES; POSITRONS; RADIOTHERAPY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; HUMAN; PERFUSION COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RECTUM CANCER;

AGED; DOSE FRACTIONATION; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84855846505     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.029     Document Type: Article

References (48)

1. G. Frykholm, B. Glimelius, and L. Pahlman Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primarily non-resectable adenocarcinoma of the rectum. Results from two consecutive studies Eur J Cancer Clin Oncol 25 1989 1535 1541
2. R. Sauer, H. Becker, and W. Hohenberger Preoperative vs. postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
3. D. Sebag-Montefiore Developments in the use of chemoradiotherapy in rectal cancer Colorectal Dis 8 Suppl 3 2006 14 17
4. D.J. Dinter, K. Horisberger, and C. Zechmann Can dynamic MR imaging predict response in patients with rectal cancer undergoing cetuximab-based neoadjuvant chemoradiation? Onkologie 32 2009 86 93
5. E. Hindie, C. Hennequin, and J.L. Moretti Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: Prognostic value and possible role in patient management Eur J Nucl Med Mol Imaging 34 2007 1576 1582
6. L.F. de Geus-Oei, D. Vriens, and H.W. van Laarhoven Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: A systematic review J Nucl Med 50 Suppl 1 2009 43S 54S
7. M.H. Janssen, H.J. Aerts, and R.G. Kierkels Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: Sequential perfusion-CT findings Radiother Oncol 94 2010 156 160
8. C. Capirci, L. Rampin, and P.A. Erba Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy Eur J Nucl Med Mol Imaging 34 2007 1583 1593
9. C. Capirci, D. Rubello, and F. Chierichetti Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy AJR Am J Roentgenol 187 2006 W202 208
10. R.F. Vliegen, R.G. Beets-Tan, and B. Vanhauten Can an FDG-PET/CT Predict Tumor Clearance of the Mesorectal Fascia after Preoperative Chemoradiation of Locally Advanced Rectal Cancer? Strahlenther Onkol 184 2008 457 464
11. V. Kalff, C. Duong, and E.G. Drummond Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery J Nucl Med 47 2006 14 22
12. H. Amthauer, T. Denecke, and B. Rau Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology Eur J Nucl Med Mol Imaging 31 2004 811 819
13. T. Denecke, B. Rau, and K.T. Hoffmann Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? Eur Radiol 15 2005 1658 1666
14. J.G. Guillem, H.G. Moore, and T. Akhurst Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining longterm outcomes of rectal cancer J Am Coll Surg 199 2004 1 7
15. G.B. Melton, W.C. Lavely, and H.A. Jacene Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy J Gastrointest Surg 11 2007 961 969 discussion 969
16. G.L. Cascini, A. Avallone, and P. Delrio 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer J Nucl Med 47 2006 1241 1248
17. R. Rosenberg, K. Herrmann, and R. Gertler The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT Int J Colorectal Dis 24 2009 191 200
18. M.H. Janssen, M.C. Ollers, and R.G. Riedl Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging Int J Radiat Oncol Biol Phys 77 2010 392 399
19. M.H. Janssen, M.C. Ollers, and R.G. Stiphout Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer Radiother Oncol 95 2010 203 208
20. D.V. Sahani, S.P. Kalva, and L.M. Hamberg Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations Radiology 234 2005 785 792
21. M. Bellomi, G. Petralia, and A. Sonzogni CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: Initial experience Radiology 244 2007 486 493
22. M.S. Park, E. Klotz, and M.J. Kim Perfusion CT: Noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy Radiology 250 2009 110 117
23. J. Wang, N. Wu, M.D. Cham, and Y. Song Tumor response in patients with advanced non-small cell lung cancer: Perfusion CT evaluation of chemotherapy and radiation therapy AJR Am J Roentgenol 193 2009 1090 1096
24. A. Zima, R. Carlos, and D. Gandhi Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 28 2007 328 334
25. A.M. Groves, G.C. Wishart, and M. Shastry Metabolic-flow relationships in primary breast cancer: Feasibility of combined PET/dynamic contrast-enhanced CT Eur J Nucl Med Mol Imaging 36 2009 416 421
26. K.A. Miles Perfusion CT for the assessment of tumour vascularity: Which protocol? Br J Radiol 76 Spec No 1 2003 S36 S42
27. K.A. Miles, M.R. Griffiths, and M.A. Fuentes Standardized perfusion value: Universal CT contrast enhancement scale that correlates with FDG PET in lung nodules Radiology 220 2001 548 553
28. K.A. Miles, M.R. Griffiths, and C.J. Keith Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: A study using quantitative contrast-enhanced computer tomography and positron emission tomography Eur J Nucl Med Mol Imaging 33 2006 22 28
29. V. Goh, S. Halligan, and L. Gartner Quantitative colorectal cancer perfusion measurement by multidetector-row CT: Does greater tumour coverage improve measurement reproducibility? Br J Radiol 79 2006 578 583
30. C. Harvey, A. Dooher, and J. Morgan Imaging of tumour therapy responses by dynamic CT Eur J Radiol 30 1999 221 226
31. R.G. Kierkels, W.H. Backes, and M.H. Janssen Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer Int J Radiat Oncol Biol Phys 77 2010 400 408
32. R. Hermans, P. Lambin, and A. Van der Goten Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma Radiother Oncol 53 1999 105 111
33. R. Hermans, and W. Van den Bogaert Outcome prediction after surgery and chemoradiation of head-and-neck squamous cell carcinoma (HNSCC), using baseline perfusion computed tomography (CT) microcirculatory parameters vs. tumor volume Int J Radiat Oncol Biol Phys 74 2009 1307 author reply 1307
34. K. Hayano, K. Shuto, and K. Koda Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer Dis Colon Rectum 52 2009 1624 1629
35. H.J. Aerts, N.A. van Riel, and W.H. Backes System identification theory in pharmacokinetic modeling of dynamic contrast-enhanced MRI: Influence of contrast injection Magn Reson Med 59 2008 1111 1119
36. P.S. Tofts, G. Brix, and D.L. Buckley Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols J Magn Reson Imaging 10 1999 223 232
37. J.F. Daisne, M. Sibomana, and A. Bol Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: Influence of reconstruction algorithms Radiother Oncol 69 2003 247 250
38. M. Ollers, G. Bosmans, and A. van Baardwijk The integration of PET-CT scans from different hospitals into radiotherapy treatment planning Radiother Oncol 87 2008 142 146
39. S. Beaulieu, P. Kinahan, and J. Tseng SUV varies with time after injection in (18)F-FDG PET of breast cancer: Characterization and method to adjust for time differences J Nucl Med 44 2003 1044 1050
40. J.F. Eary, and D.A. Mankoff Tumor metabolic rates in sarcoma using FDG PET J Nucl Med 39 1998 250 254
41. J.U. Harrer, G.J. Parker, and H.A. Haroon Comparative study of methods for determining vascular permeability and blood volume in human gliomas J Magn Reson Imaging 20 2004 748 757
42. A. Jackson, G.C. Jayson, and K.L. Li Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma Br J Radiol 76 2003 153 162
43. S. Walker-Samuel, M.O. Leach, and D.J. Collins Reference tissue quantification of DCE-MRI data without a contrast agent calibration Phys Med Biol 52 2007 589 601
44. M.H. Janssen, M.C. Ollers, and R.G. van Stiphout Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: Sequential FDG-PET-CT findings Radiother Oncol 94 2010 151 155
45. P. Burgman, J.A. Odonoghue, J.L. Humm, and C.C. Ling Hypoxia-Induced increase in FDG uptake in MCF7 cells J Nucl Med 42 2001 170 175
46. R.A. Dierckx, and C. Van de Wiele FDG uptake, a surrogate of tumour hypoxia? Eur J Nucl Med Mol Imaging 35 2008 1544 1549
47. M. Busk, M.R. Horsman, and S. Jakobsen Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage Eur J Nucl Med Mol Imaging 35 2008 2294 2303
48. Q.G. de Lussanet, W.H. Backes, and A.W. Griffioen Dynamic contrast-enhanced magnetic resonance imaging of radiation induced therapy-induced microcirculation changes in rectal cancer Int J Radiat Oncol Biol Phys 63 2005 1309 1315